Lasmiditan
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Lasmiditan is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Lasmiditan is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $88.70 to $88.77 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$88.70 – $88.77
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing LASMIDITAN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REYVOW 100 MG TABLET | $88.7715 per EA | — |
REYVOW 50 MG TABLET | $88.6973 per EA | — |
Frequently Asked Questions
What is Lasmiditan used to treat?
Lasmiditan is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
How many Lasmiditan products are on the market?
The Lasmiditan drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Lasmiditan?
NADAC reference prices for Lasmiditan range from $88.6973 to $88.7715 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Lasmiditan?
1 manufacturer lists Lasmiditan in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (2).